Animal Growth Promoters & Performance Enhancers Market Research Report by Type, by Animal Type - Global Forecast to 2025 - Cumulative Impact of COVID-19
Animal Growth Promoters & Performance Enhancers Market Research Report by Type (Antibiotic Growth Promoters and Non-Antibiotic Growth Promoters & Performance Enhancers), by Animal Type (Aquatic Animals, Livestock, Poultry, and Swine) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Animal Growth Promoters & Performance Enhancers Market is expected to grow from USD 14,831.78 Million in 2020 to USD 19,669.90 Million by the end of 2025. 2. The Global Animal Growth Promoters & Performance Enhancers Market is expected to grow from EUR 13,004.79 Million in 2020 to EUR 17,246.94 Million by the end of 2025. 3. The Global Animal Growth Promoters & Performance Enhancers Market is expected to grow from GBP 11,561.28 Million in 2020 to GBP 15,332.57 Million by the end of 2025. 4. The Global Animal Growth Promoters & Performance Enhancers Market is expected to grow from JPY 1,582,927.59 Million in 2020 to JPY 2,099,277.59 Million by the end of 2025. 5. The Global Animal Growth Promoters & Performance Enhancers Market is expected to grow from AUD 21,537.72 Million in 2020 to AUD 28,563.32 Million by the end of 2025.
Market Segmentation & Coverage: This research report categorizes the Animal Growth Promoters & Performance Enhancers to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Animal Growth Promoters & Performance Enhancers Market studied across Antibiotic Growth Promoters and Non-Antibiotic Growth Promoters & Performance Enhancers. The Non-Antibiotic Growth Promoters & Performance Enhancers further studied across Acidifiers, Feed Enzymes, Hormones, Phytogenics, and Prebiotics & Probiotics.
Based on Animal Type, the Animal Growth Promoters & Performance Enhancers Market studied across Aquatic Animals, Livestock, Poultry, and Swine.
Based on Geography, the Animal Growth Promoters & Performance Enhancers Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Growth Promoters & Performance Enhancers Market including Alltech, Inc., Archer-Daniels-Midland Company, Associated British Foods PLC, Bupo Animal Health, Cargill, Inc., Chr. Hansen, Elanco Animal Health Inc., Erber AG, Kemin Industries, Merck & Co., Inc., Novus International, Inc., Nutreco, Phibro Animal Health Corporation, Royal DSM N.V., and Vetoquinol.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch™ FPNV Positioning Matrix: The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Growth Promoters & Performance Enhancers Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch™ Competitive Strategic Window: The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as: 1. What is the market size and forecast of the Global Animal Growth Promoters & Performance Enhancers Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Growth Promoters & Performance Enhancers Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Growth Promoters & Performance Enhancers Market? 4. What is the competitive strategic window for opportunities in the Global Animal Growth Promoters & Performance Enhancers Market? 5. What are the technology trends and regulatory frameworks in the Global Animal Growth Promoters & Performance Enhancers Market? 6. What are the modes and strategic moves considered suitable for entering the Global Animal Growth Promoters & Performance Enhancers Market?
Our reports have been used by over 10K customers, including:
Pathology Devices Market Report Overview Pathology Devices market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pathology Devices market types and applications. It is a focused study on Pathology Devices market space including global and...
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
The Middle East & Africa organoids market is expected to reach US$ 141.26 million in 2027 from US$ 37.34 million in 2019; the market is estimated to grow at a CAGR of 20.9% from 2020 to 2027. The growth of the market can be attributed to growing research on organoids in the Middle East & Africa region and rising focus on developing alternatives...
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The South and Central America nurse call systems market is expected to reach US$ 200.11 million by 2027 from US$ 87.23 million in 2019. The market is estimated to grow at a CAGR of 10.8% from 2020-2027. The growth of the South and Central America nurse call systems market is driven by the growing incidence of Alzheimer’s disease and dementia...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
Abstract Fleet Telematics Systems Procurement in the US This report is intended to assist buyers of fleet telematics systems. Fleet telematics systems are used to monitor, map and track vehicle fleets in the field. Digital maps and Global Positioning System (GPS) technology allow for real-time visualization...
The Europe Ultrasonic Sensors Market would witness market growth of 8.9% CAGR during the forecast period (2020-2026). Ultrasonic sensors delivering real-time visual analysis, which capitalizes during the rising examples of complex medical conditions like cardiovascular disease, orthopedic, and cranial nerve disease, which requires non-invasive...
The global apheresis equipment market grew at a CAGR of around 12% during 2014-2019. Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced...
Pathology
Chronic Disease
Infectious Disease
Research And Development
Neurological Disorder
Blood Supply
World
Chronic Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.